The prevalence and antimicrobial resistance of Haemophilus influenzae in prepubertal girls with vulvovaginitis

DOI: https://doi.org/10.21203/rs.3.rs-41705/v1

Abstract

Background: To determine the prevalence of Haemophilus influenzae vulvovaginitis in prepubertal girls and the antimicrobial resistance of H.influenzae strains isolated from vulval specimens.

Methods: Isolates of H.influenzae from vulval swabs of prepubertal girls with vulvovaginitis received at The Children's Hospital, Zhejiang University School of Medicine during 2016-2019 were studied. Vulval specimens were inoculated on Haemophilus selective chocolate agar. Antimicrobial susceptibility tests were performed using the disk diffusion method. A cefinase disk was used to detect β-lactamase.

Results: A total of 4142 vulval specimens were received during the 4 years, 649 isolates of H. influenzae were isolated from 642 girls aged 6 months to 13 years, with a median of 5y. There were peaks of isolates from April to July seen in the vulval isolates. In total, the ampicillin resistance rate was 39.1% (250/640); 33.2% strains (211/636) were for β-lactamase-positive isolates, 6.6% strains (42/635) were β-lactamase-negative and ampicillin-resistant (BLNAR) isolates. The resistance rates of H. influenzae isolates to amoxycillin-clavulanic acid, ampicillin-sulbactam, cefuroxime, ceftriaxone, cefotaxime, meropenem, levofloxacin, sulfamethoxazole-trimethoprim, azithromycin, and chloramphenicol were 26.4%, 21.8%, 24.8%, 1.7%, 1.0%, 0.2%, 0%, 47.7%, 10.2%, and 1.1%, respectively. MDR was present in 41 (6.4%) of the 642 H. influenzae isolates, with the most prevalent MDR phenotype of ampicillin-sulfamethoxazole-trimethoprim-azithromycin resistance.

Conclusions: H. influenzae is a common cause of vulvovaginitis in prepubertal girls. Laboratories should ensure that they include media appropriate for the isolation of H. influenzae. It’s worth noting of ampicillin resistance of H. influenzae in clinical management.

Background

Vulvovaginitis is a common problem in prepubertal girls, which is most commonly attributed to poor hygiene or nonspecific irritants, but can occur as a part of bacterial infection[1]. Several studies have reported that Streptococcus pyogenes and Haemophilus influenzae (H. influenzae) are the most common bacterial causes of juvenile vulvovaginitis[14]. The association between H.influenzae and prepubertal vulvovaginitis was first highlighted by MacFarlane in 1987[5]. But Cox RA’s study in 1997 showed that H. influenzaewas an underrated cause of vulvovaginitis in young girls[4]. However, until now, few studies have comprehensively explored the prevalence of H. influenzae vulvovaginitis in prepubertal girls. Furthermore, published studies that included a large sample size are also scarce. Therefore, we described a four-year study, undertaken in the laboratory of a tertiary university hospital, to determine the prevalence of H. influenzae vulvovaginitis in prepubertal girls and the antimicrobial resistance of H.influenzae strains isolated from vulval specimens.

Methods

Strain Collection and Identification

This was a retrospective analysis of data from prepubertal girls who presented to the outpatient clinic of pediatric and adolescent gynecology at The Children’s Hospital, Zhejiang University School of Medicine between January 2016 and December 2019. Two vulval swabs were taken from each girl, one for microscopic examination and the other for cultivation. The finding of a large number of polymorphonuclear leukocytes on Gram-stained smears indicated the presence of inflammatory reaction. The specimens were inoculated directly onto Columbia blood agar, Chocolate agar (Haemophilus and Gonorrhoeae selective chocolate agar), and Sabouraud’s agar plates in air or 5% CO2, as appropriate, at 35 °C for 24–48 h. Suspected pathogens on Haemophilus selective chocolate agar were identified by standard methods using Matrix Assisted Laser Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS, Bruker).

β -Lactamase Detection and Antimicrobial Susceptibility Test

The antimicrobial susceptibility test by disk diffusion was performed and interpreted according to the Clinical Laboratory Standards Institute (CLSI) guidelines M100-S29with antibiotics ampicillin (10 µg), amoxycillin-clavulanic acid (20 µg/10 µg), ampicillin-sulbactam (10 µg/10 µg), cefuroxime (30 µg), ceftriaxone (30 µg), cefotaxime (30 µg), meropenem (10 µg), levofloxacin (5 µg), sulfamethoxazole-trimethoprim (1.25/23.75 µg), azithromycin (15 µg), and chloramphenicol (30 µg) (Oxoid, UK). β-lactamase was measured using the cefinase disc method (BioMérieux, France). H. influenzae strain ATCC49247 was used for quality control throughout the test. Multi-Drug Resistance (MDR) was defined as resistant to three or more than three different types of antibiotics.

Statistical Analysis

Antibiotic resistant rates were analyzed with WHONET 5.6. Comparisons of antibiotic resistant rate between groups were performed with the X2 test. Age data, which were non-normally distributed, were described as medians (IQR). P values < 0.05 were considered statistically significant.

Results

Sources of Isolates

From January 2016 to December 2019 a total of 4142vulval swabs from children were received, increasing from 803 in 2016 to 1488 in 2019. In total, 649 swabs (15.7%) from 642 patients yielded H. influenzae. Table 1 shows the yearly totals with an increase in numbers received but a decrease in proportion of positives for H. influenzae. The monthly totals for positive isolates of H. influenzae show some peaks and troughs throughout the year (Fig. 1). The numbers of isolates per month ranged from 2 in October 2017 to a maximum of 27 in July 2019. There were peaks of isolates from April to July seen in the vulval isolates. The age range of children carrying the H. influenzae isolates was from 0.5y to 13y but 477 (75%) were between the ages of 3 and 7 years, with a median of 5y (IQR: 3)(Fig. 2).

Table 1

Yearly distribution of H. influenzae strains isolated from vulval specimens, 2016–2019

Year

Total received

H. influenzae positives

N

%

2016

803

149

18.6

2017

931

144

15.5

2018

920

155

16.8

2019

1488

194

13.0

Total

4142

642

15.5

β -Lactamase Detection and Antimicrobial Susceptibility Test

In total, the ampicillin resistance rate was 39.1% (250/640); 33.2% strains (211/636) were for β-lactamase-positive isolates, 6.6% strains (42/635) were β-lactamase-negative and ampicillin-resistant (BLNAR) isolates. The resistance rates of the H. influenzae isolates toamoxycillin-clavulanic acid, ampicillin-sulbactam, cefuroxime, ceftriaxone, cefotaxime, meropenem, levofloxacin, sulfamethoxazole-trimethoprim, azithromycin, and chloramphenicol were 26.4%, 21.8%, 24.8%, 1.7%, 1.0%, 0.2%, 0%, 47.7%, 10.2%, and 1.1%, respectively (Table 2). In different years, the resistance rates of H. influenzae strains to cefuroxime and azithromycin had a significantly statistical difference (P < 0.05; Table 3). β-lactamase-positive H. influenzae strains had significantly higher resistance rates to ampicillin, amoxycillin-clavulanic acid, cefuroxime, sulfamethoxazole-trimethoprim, azithromycin, and chloramphenicol than β-lactamase-negative strains did (P < 0.01; Table 4). BLNAR H. influenzae strains were all resistant to amoxycillin-clavulanic acid, ampicillin-sulbactam and cefuroxime while all susceptible to levofloxacin, azithromycin and chloramphenicol (Table 5).

Table 2

Antibiotic resistances of H. influenzae strains isolated from vulval specimens, 2016–2019

Antibiotic

N

%R

%I

%S

β-lactamase

636

33.2

 

66.8

Ampicillin

640

39.1

6.6

54.4

Amoxycillin-clavulanic acid

349

26.4

0

73.6

Ampicillin-sulbactam

641

21.8

0

78.2

Cefuroxime

640

24.8

2.5

72.7

Ceftriaxone

350

1.7

0

98.3

Cefotaxime

288

1

0

99

Meropenem

632

0.2

0

99.8

Levofloxacin

640

0

0

100

Sulfamethoxazole-trimethoprim

641

47.7

1.4

50.9

Azithromycin

469

10.2

0

89.8

Chloramphenicol

641

1.1

0

98.9

Note: S, susceptible; I, intermediate; R, resistant; * rate ofnon-susceptible.

Table 3

Antibiotic resistances of H. influenzae strains isolated from vulval specimens in different years

Antibiotic

2016

2017

2018

2019

N

%R

N

%R

N

%R

N

%R

β-lactamase

148

31.8

142

26.8

156

35.9

192

37

Ampicillin

148

33.1

145

37.2

155

41.9

194

42.8

Amoxycillin-clavulanic acid

/

/

/

/

154

23.4

194

28.9

Ampicillin-sulbactam

149

16.1

145

26.9

155

21.3

194

22.7

Cefuroxime#

149

17.4

145

26.2

154

23.4

194

30.4

Ceftriaxone

/

/

/

/

155

1.3

194

2.1

Cefotaxime

146

1.4

143

0.7

/

/

/

/

Meropenem

148

0

137

0.7

155

0

194

0

Levofloxacin

148

0

145

0

155

0

194

0

Sulfamethoxazole-trimethoprim

149

49

145

45.5

155

47.7

194

48.5

Azithromycin#

/

/

/

/

155

7.1

191

14.7

Chloramphenicol

149

1.3

145

1.4

155

0

194

1.5

Note: R, resistant; * rate of non-susceptible.

Table 4

Comparison of antibiotic resistance between β-lactamase-positive and β-lactamase-negative H. influenzae strains isolated from vulval specimens, 2016–2019

Antibiotic

β-lactamase (+)

β-lactamase (-)

N

%R

%I

%S

N

%R

%I

%S

Ampicillin1

211

98.6

0.5

0.9

424

9.9

9.4

80.7

Amoxycillin-clavulanic acid1

126

38.9

0

61.1

222

18.9

0

81.1

Ampicillin-sulbactam2

212

26.9

0

73.1

424

19.6

0

80.4

Cefuroxime1

212

33

6.6

60.4

423

21

0.5

78.5

Ceftriaxone

127

3.1*

0

96.9

222

0.9*

0

99.1

Cefotaxime

83

1.2*

0

98.8

201

1*

0

99

Meropenem

210

0

0

100

417

0.2*

0

99.8

Levofloxacin

211

0

0

100

424

0

0

100

Sulfamethoxazole-trimethoprim1

212

59.4

0.5

40.1

424

42

1.9

56.1

Azithromycin1

161

28*

0

72

307

1*

0

99

Chloramphenicol1

212

3.3

0

96.7

424

0

0

100

Note: S, susceptible; I, intermediate; R, resistant; * rate ofnon-susceptible; 1P<0.01; 2P<0.05.

Table 5

Antibiotic resistances of BLNAR H. influenzae strains isolated from vulval specimens, 2016–2019

Antibiotic

N

%R

%I

%S

Amoxycillin-clavulanic acid

22

100

0

0

Ampicillin-sulbactam

42

100

0

0

Cefuroxime

42

100

0

0

Ceftriaxone

22

9.1*

0

90.9

Cefotaxime

20

10*

0

90

Meropenem

36

2.8*

0

97.2

Levofloxacin

42

0

0

100

Sulfamethoxazole-trimethoprim

42

47.6

9.5

42.9

Azithromycin

24

0

0

100

Chloramphenicol

42

0

0

100

Note: S, susceptible; I, intermediate; R, resistant; * rate ofnon-susceptible.

MDR Pattern

MDR was present in 41 (6.4%) of the 642 H. influenzae isolates. The most prevalent resistance phenotype was ampicillin-sulfamethoxazole-trimethoprim-azithromycin resistance, which was detected in 16 isolates, representing 39% of MDR strains (Table 6).

Table 6

The main MDR patterns of H. influenzae strains isolated from vulval specimens, 2016–2019

MDR pattern

Number of isolates

Percent (%)

β-lactams-SXT-AZM

   

AMP-SXT-AZM

16

39.0

AMP-CXM-SXT-AZM

4

9.8

AMP-CXM-AMC-SXT-AZM

3

7.3

AMP-CXM-SAM-AMC-SXT-AZM

3

7.3

AMP-AMC-SXT-AZM

2

4.9

AMC-SXT-AZM

1

2.4

AMP-CXM-SAM-SXT-AZM

1

2.4

SAM-SXT-AZM

1

2.4

CXM-SXT-AZM

1

2.4

AMP-SAM-AMC-SXT-AZM

1

2.4

AMP-CXM-SAM-AMC-CRO-SXT-AZM

1

2.4

β-lactams-SXT-CHL

   

AMP-SXT-CHL

3

7.3

AMP-AMC-SXT-CHL

1

2.4

AMP-SAM-SXT-CHL

1

2.4

AMP-CXM-SXT-CHL

1

2.4

β-lactams-SXT-AZM-CHL

   

AMP-SXT-AZM-CHL

1

2.4

Note: AMP, Ampicillin; CXM, Cefuroxime; SAM, Ampicillin-sulbactam; AMC, Amoxycillin-clavulanic acid; CRO, Ceftriaxone; SXT, Sulfamethoxazole-trimethoprim; AZM, Azithromycin; CHL, Chloramphenicol.

Discussion

Vulvovaginitis in prepubertal children is a common complained problem in clinical practice. The anatomy of vulva and the thin uncornified vulval epithelium at prepubertal age makes it susceptible to infection[1]. Because few hospitals provide specialist paediatric gynaecological outpatient services, children with vulvovaginitis are managed mainly in primary care[3]. Therefore, there were few studies comprehensively explored the prevalence of H. influenzae vulvovaginitis in prepubertal girls. This study was performed at a tertiary university hospital, which provides specialist paediatric gynaecological outpatient services.

Vulvovaginitis caused by upper respiratory flora is generally considered to be the most common gynecological problem in prepubertal girls. A multicenter study showed that paediatric inflammatory vulvovaginitis is mainly caused by pathogens of the upper respiratory tract and the most common risk factor for this infection is to have suffered an upper respiratory tract infection in the previous month[6]. A study of case report provided the direct evidence of the nose-hand-vagina method of transmission[7]. It has been assumed that respiratory bacteria were transmitted to the perineal area via the hands[8]. Therefore, advice on hygiene and behavior may be an important strategy to prevent vulvovaginitis in prepubertal girls.

Several previous studies have indicated that vulvovaginitis in girls is mostly caused by the bacteria from the upper respiratory tract, S. pyogenes and H. influenzae[1]. In a large study from Liverpool, H. influenzae was a more common cause of this complaint than β haemolytic streptococci[9]. However, H. influenzae is fastidious in its growth requirements and laboratories may not isolate it unless they include appropriate culture medium for genital swabs received for young girls[10]. In the present study, all the specimens were inoculated onto Haemophilus selective chocolate agar for the isolation of H. influenzae. Published studies have described a large number of Gram-negative and Gram-positive bacteria as the possible causes of vulvovaginitis in girls. However, the pure or predominant growth of a possible pathogenic microorganism, associated with the signs of inflammation, is certainly of diagnostic relevance[1]. In this study, the finding of a large number of polymorphonuclear leukocytes on Gram-stained smears was used to indicate the presence of inflammatory reaction, which ensured that the H. influenzae isolated from vulval swabs was a possible pathogenic microorganism. There were 649 (15.7%) of 4142 vulval swabs from children yielded H. influenzae in this study, which was in agreement with the opinions described above that vulvovaginitis in girls is mostly caused by the bacteria from the upper respiratory tract, S. pyogenes and H. influenzae, suggesting that H. influenzae was a common pathogen of vulvovaginal infection in prepubertal girls in Zhejiang, China. There were peaks of isolates from April to July seen in the vulval isolates, which was consistent with that from the respiratory tract specimens, suggesting that vaginal H. influenzae strains might from the respiratory tract[6, 11]. The age range of children carrying the H. influenzae isolates was from 0.5y to 13y but 477 (75%) were between the ages of 3 and 7 years, which were in agreement with the results of previous studies[11, 12].

Ampicillin became the drug of choice for the treatment of H. influenzae infections since the 1970s[13]. In recent years, with the extensive use of antibiotics, the drug resistance of H. influenzae strains to ampicillin has gradually increased. The ampicillin resistance rate of H. influenzae strains in China was increased from12% in 2000–2002[14] to 58.1% in 2016[15]. In this study, the ampicillin resistance rate was 39.1%, which was higher than that in genital strains (26.4%) but lower than that in respiratory strains (58.4%)in 2015 reported by our study team[15]. In different years, the ampicillin resistance of H. influenzae strains isolated from vulval specimens had gradually increased, from 33.1% in 2016 to 42.8% in 2018.Therefore, it’s worth noting of ampicillin resistance of H. influenzae in clinical management. However, the production of β-lactamase is still the main mechanism of ampicillin resistance of H. influenzae strains in this study, which was consistent with the results in other reports[12, 16, 17], but different from the mechanism in Japan (BLNAR accounted for > 50% after 2014)[18], while BLNAR accounted for only 6.6% in our study, suggesting great differences in antibiotic resistance and drug-resistant mechanisms of H. influenzae strains around the world. There have been studies comparing the H. influenzae resistance profiles between respiratory tract and urinary tract[19], respiratory isolates and vaginal isolates [11], the resistance profiles of H. influenzae vary greatly depending on the infection site, which indicated that the optimal antibiotic treatment for H. influenzae might vary depending on the region and the site of infection. For BLNAR strains, these drugs should be avoided to use with the reason that BLNAR H. influenzae strains were all resistant to amoxycillin-clavulanic acid, ampicillin-sulbactam and cefuroxime. The resistance rates of the H. influenzae isolates to amoxycillin-clavulanic acid, and ampicillin-sulbactam were 26.4%, 21.8% in this study, which might be attributed to BLNAR strains and β-lactamase-producing clavulanic acid/amoxicillin-resistant (BLPACR) strains of H. influenzae. The mechanisms of BLPACR strains might be β-lactamase and PBP amino acid substitutions[20].

Generally, H. influenzae strains are highly susceptible to third-generation cephalosporins. The non-susceptibility rate of H. influenzae to third-generation cephalosporins was under 2% in the present study, which was much lower than that in Iran (33.1%)[21] and Japan (49.4%) [22], but similar to the rate of genital strains in china in 2015(5.5%), a reason for the differences might be explained by the different sites of infection. Typically, H. influenzae is sensitive to carbapenem; however, carbapenem-non-susceptible H. influenzae has been reported previously [23]. In this study, we found one H. influenzae strain non-susceptible to meropenem; its mechanism is worthy to research in further study.

A high prevalence of sulfamethoxazole-trimethoprim resistance (47.7%) among H. influenzae isolates was found in this study. However, no significant difference was found between the current results (47.7%, 306/641) in 2016–2019 and the previous results in 2015 (51.8%, 57/110)[11], which might be because of fewer applications of sulfamethoxazole-trimethoprim. There were 10.2% of the H. influenzae isolates resistant to azithromycin in this study, and a significantly increased resistance was seen between 2018 and 2019, which might because the extensive use of azithromycin in respiratory infections in China. H. influenzae strains were all sensitive to levofloxacin in the study; and 1.1% of H. influenzae strains were resistant to chloramphenicol, which might because of that these antibiotics are not used in children in China. However, ofloxacin or levofloxacin gel is still widely used as topical antibiotics in treating local infections in China, including prepubertal vulvovaginitis. MDR was present in 41 (6.4%) of the 642 H. influenzae isolates. The most prevalent resistance phenotype was ampicillin-sulfamethoxazole-trimethoprim-azithromycin resistance, which was in accordance with the previous findings[15].

Conclusions

To our knowledge, this study currently represents the largest population-based study of H. influenzae vulvovaginitis in prepubertal girls in China. H. influenzae is a common cause of vulvovaginitis in prepubertal girls in Zhejiang, China. Laboratories should ensure that they include media appropriate for the isolation of H. influenzae. It’s worth noting of ampicillin resistance of H. influenzae in clinical management. Advice on hygiene and behavior may be an important strategy to prevent vulvovaginitis in prepubertal girls.

Abbreviations

H.influenzae

Haemophilus influenzae; CLSI:Clinical and laboratory standards institute; MDR:Multi-Drug Resistance; BLNAR:β-lactamase-negative and ampicillin-resistant;

Declarations

Ethics approval and consent to participate

The study obtained approval from the Research and Ethics committee of The Children's Hospital, Zhejiang University School of Medicine (2019-IRB-049). The Ethics Committee waived the requirement for informed consent as the investigated isolates were obtained from clinical specimens referred to the diagnostic laboratory as part of routine care.

Consent for publication

Not applicable.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Competing interests

The authors declare no conflicts of interest.

Funding

Not applicable

Authors' contributions

Liying Sun, Xuejun Chen and Chunzhen Hua guided in the study design; Mingming Zhou and Xuejun Chen performed analysis and interpretation of data and drafted the manuscript; Mingming Zhou, Chao Fang and Jianping Li participated in strain identification and antimicrobial susceptibility test. All authors have read and approved the final manuscript.

Acknowledgements

Not applicable

References

  1. Randelovic G, Mladenovic V, Ristic L, Otasevic S, Brankovic S, Mladenovic-Antic S, Bogdanovic M, Bogdanovic D. Microbiological aspects of vulvovaginitis in prepubertal girls. Eur J Pediatr. 2012;171(8):1203–8.
  2. Sikanic-Dugic N, Pustisek N, Hirsl-Hecej V, Lukic-Grlic A. Microbiological findings in prepubertal girls with vulvovaginitis. Acta Dermatovenerol Croat. 2009;17(4):267–72.
  3. Cox RA, Slack MP. Clinical and microbiological features of Haemophilus influenzae vulvovaginitis in young girls. J Clin Pathol. 2002;55(12):961–4.
  4. Cox RA. Haemophilus influenzae: an underrated cause of vulvovaginitis in young girls. J Clin Pathol. 1997;50(9):765–8.
  5. Macfarlane DE, Sharma DP. Haemophilus influenzae and genital tract infections in children. Acta Paediatr Scand. 1987;76(2):363–4.
  6. Cuadros J, Mazon A, Martinez R, Gonzalez P, Gil-Setas A, Flores U, Orden B, Gomez-Herruz P, Millan R. Spanish Study Group for Primary Care I. The aetiology of paediatric inflammatory vulvovaginitis. Eur J Pediatr. 2004;163(2):105–7.
  7. Chen X, Chen L, Zeng W, Zhao X. Haemophilus influenzae vulvovaginitis associated with rhinitis caused by the same clone in a prepubertal girl. J Obstet Gynaecol Res. 2017;43(6):1080–3.
  8. Hansen MT, Sanchez VT, Eyster K, Hansen KA. Streptococcus pyogenes pharyngeal colonization resulting in recurrent, prepubertal vulvovaginitis. J Pediatr Adolesc Gynecol. 2007;20(5):315–7.
  9. Pierce AM, Hart CA. Vulvovaginitis: causes and management. Arch Dis Child. 1992;67(4):509–12.
  10. Macsween KF, Ridgway GL. The laboratory investigation of vaginal discharge. J Clin Pathol. 1998;51(8):564–7.
  11. Li JP, Hua CZ, Sun LY, Wang HJ, Chen ZM, Shang SQ. Epidemiological Features and Antibiotic Resistance Patterns of Haemophilus influenzae Originating from Respiratory Tract and Vaginal Specimens in Pediatric Patients. J Pediatr Adolesc Gynecol. 2017;30(6):626–31.
  12. Kim H, Chai SM, Ahn EH, Lee MH. Clinical and microbiologic characteristics of vulvovaginitis in Korean prepubertal girls, 2009–2014: a single center experience. Obstet Gynecol Sci. 2016;59(2):130–6.
  13. Tristram S, Jacobs MR, Appelbaum PC. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev. 2007;20(2):368–89.
  14. Shen XZ, Lu Q, Deng L, Yu S, Zhang H, Deng Q, Jiang M, Hu Y, Yao KH, Yang YH. Resistance of Haemophilus influenzae isolates in children under 5 years old with acute respiratory infections in China between 2000 and 2002. J Int Med Res. 2007;35(4):554–63.
  15. Wang HJ, Wang CQ, Hua CZ, Yu H, Zhang T, Zhang H, Wang SF, Lin AW, Cao Q, Huang WC, et al. Antibiotic Resistance Profiles of Haemophilus influenzae Isolates from Children in 2016: A Multicenter Study in China. Can J Infect Dis Med Microbiol. 2019; 2019:6456321.
  16. Fluit AC, Florijn A, Verhoef J, Milatovic D. Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J Antimicrob Chemother. 2005;56(1):133–8.
  17. Wang CY, Xu HM, Deng JK, Yu H, Chen YP, Lin AW, Cao Q, Hao JH, Zhang T, Deng HL, et al. A multicentric clinical study on clinical characteristics and drug sensitivity of children with pneumococcal meningitis in China. Zhonghua Er Ke Za Zhi. 2019;57(5):355–62.
  18. Yamada S, Seyama S, Wajima T, Yuzawa Y, Saito M, Tanaka E, Noguchi N. beta-Lactamase-non-producing ampicillin-resistant Haemophilus influenzae is acquiring multidrug resistance. J Infect Public Health. 2019.
  19. Deguchi T, Ito S, Hatazaki K, Horie K, Yasuda M, Nakane K, Mizutani K, Tsuchiya T, Yokoi S, Hanaoka N, et al. Antimicrobial susceptibility of Haemophilus influenzae strains isolated from the urethra of men with acute urethritis and/or epididymitis. J Infect Chemother. 2017;23(11):804–7.
  20. Matic V, Bozdogan B, Jacobs MR, Ubukata K, Appelbaum PC. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J Antimicrob Chemother. 2003;52(6):1018–21.
  21. Vaez H, Sahebkar A, Pourfarzi F, Yousefi-Avarvand A, Khademi F. Prevalence of Antibiotic Resistance of Haemophilus Influenzae in Iran- A Meta-Analysis. Iran J Otorhinolaryngol. 2019;31(107):349–57.
  22. Nagai K, Kimura O, Domon H, Maekawa T, Yonezawa D, Terao Y. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children with acute otitis media in Japan from 2014 to 2017. J Infect Chemother. 2019; 25(3):229 – 32.
  23. Kitaoka K, Kimura K, Kitanaka H, Banno H, Jin W, Wachino JI, Arakawa Y. Carbapenem-Nonsusceptible Haemophilus influenzae with Penicillin-Binding Protein 3 Containing an Amino Acid Insertion. Antimicrob Agents Chemother. 2018; 62(8).